Literature DB >> 23912684

Elucidating the mechanism by which Gypsum fibrosum, a traditional Chinese medicine, maintains cutaneous water content.

Nobutomo Ikarashi1, Naoki Ogiue, Eri Toyoda, Marina Nakamura, Risako Kon, Yoshiki Kusunoki, Takashi Aburada, Makoto Ishii, Yoshikazu Tanaka, Yoshiaki Machida, Wataru Ochiai, Kiyoshi Sugiyama.   

Abstract

Aquaporin-3 (AQP3) plays an important role in maintaining the normal water content of the skin. Previously, we revealed that the expression of cutaneous AQP3 increased following oral administration of Gypsum fibrosum (main component: CaSO₄) to mice. The purpose of this study is to elucidate the mechanism by which Gypsum fibrosum increases the expression of cutaneous AQP3 in a keratinocyte cell line. Gypsum fibrosum or CaSO₄ was added to keratinocytes, and the expression level of AQP3, the Ca concentration, the activity of protein kinase C (PKC), and the degrees of phosphorylation of both extracellular signal-regulated kinase (ERK) and cAMP response element binding protein (CREB) were measured. The mRNA and protein expression levels of AQP3 increased significantly 6 h-post addition of Gypsum fibrosum. In keratinocytes treated with Gypsum fibrosum, increases in the concentration of intracellular Ca, PKC activity, and the phosphorylation of ERK and CREB were observed. Pre-treatment with GF109203X, a PKC inhibitor, suppressed the mRNA expression levels of AQP3. Similarly to treatment with Gypsum fibrosum, the addition of CaSO₄ led to the same observations in keratinocytes. It is hypothesized that Gypsum fibrosum causes an increase in the intracellular Ca concentration, PKC activity, and the phosphorylation levels of ERK and CREB, resulting in increased AQP3 expression in keratinocytes. In addition, it is possible that the effect of Gypsum fibrosum is attributable to CaSO₄, based on the results demonstrating that the mechanisms of action of Gypsum fibrosum and CaSO₄ were nearly identical.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23912684     DOI: 10.1248/bpb.b13-00494

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  Herbal formula SC-E1 suppresses lipopolysaccharide-stimulated inflammatory responses through activation of Nrf2/HO-1 signaling pathway in RAW 264.7 macrophages.

Authors:  Ju-Yeon Park; Young-Won Kwon; Soo Chil Lee; Sun-Dong Park; Ju-Hee Lee
Journal:  BMC Complement Altern Med       Date:  2017-07-28       Impact factor: 3.659

2.  Metabolic profiling and pharmacokinetic studies of Baihu-Guizhi decoction in rats by UFLC-Q-TOF-MS/MS and UHPLC-Q-TRAP-MS/MS.

Authors:  Yan He; Zhenkun Zhou; Weijie Li; Yanqiong Zhang; Ruoyao Shi; Tao Li; Linlin Jin; Hongliang Yao; Na Lin; Hao Wu
Journal:  Chin Med       Date:  2022-10-04       Impact factor: 4.546

3.  Chinese herbal medicine is associated with higher body weight reduction than liraglutide among the obese population: A real-world comparative cohort study.

Authors:  Yu-Ning Liao; Hsing-Yu Chen; Ching-Wei Yang; Pai-Wei Lee; Chiu-Yi Hsu; Yu-Tung Huang; Tsung-Hsien Yang
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

4.  Traditional chinese medicine prescriptions enhance growth performance of heat stressed beef cattle by relieving heat stress responses and increasing apparent nutrient digestibility.

Authors:  Xiaozhen Song; Junrong Luo; Daibo Fu; Xianghui Zhao; Kornmatitsuk Bunlue; Zhensong Xu; Mingren Qu
Journal:  Asian-Australas J Anim Sci       Date:  2014-10       Impact factor: 2.509

5.  Effect of Astaxanthin on the Expression and Activity of Aquaporin-3 in Skin in an In-Vitro Study.

Authors:  Nobutomo Ikarashi; Risako Kon; Chika Nagoya; Airi Ishikura; Yuri Sugiyama; Jiro Takahashi; Kiyoshi Sugiyama
Journal:  Life (Basel)       Date:  2020-09-11

6.  Effect of Japanese Kampo medicine, eppikajutsuto, in patients with lymphatic malformation: A retrospective observational study.

Authors:  Keiko Ogawa-Ochiai; Keigo Osuga; Taiki Nozaki; Yuko Tazuke; Seisho Sakai; Shuichiro Uehara; Reina Hoshi; Hideki Ishikawa; Kenichi Yoshimura; Hiroomi Okuyama
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.